Novel curcumin diclofenac conjugate enhanced curcumin bioavailability and efficacy in streptococcal cell wall-induced arthritis

Indian Journal of Pharmaceutical Sciences

Volumn 76, Issue 5, 2014, Pages 415-422

  Jain, S K ^a   Gill, M S ^a   Pawar, H S ^a   Suresh, Sarasija ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Curcumin; diclofenac; drug conjugate; oral bioavailability; rheumatoid arthritis

Indexed keywords

CURCUMIN; DICLOFENAC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL CELL WALL; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG EFFICACY; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; ESTERIFICATION; HALF LIFE TIME; HETERONUCLEAR SINGLE QUANTUM COHERENCE; HYDROLYSIS; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; PROTEIN DENATURATION; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; RHEUMATOID ARTHRITIS; SINGLE DRUG DOSE; STEREOSPECIFICITY; STREPTOCOCCAL CELL WALL INDUCED ARTHRITIS; STREPTOCOCCUS MUTANS; THERMODYNAMICS; THERMOGRAVIMETRY; X RAY DIFFRACTION;

EID: 84908447472     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Epstein J, Sanderson IR, MacDonald TT. Curcumin as a therapeutic agent: The evidence from in vitro, animal and human studies. Br J Nutr 2010;103:1545-57.
2. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as ''Curcumin'': From kitchen to clinic. Biochem Pharmacol 2008;75:787-809.
3. Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett 2005;223:181-90.
4. Jayaprakasha G, Jaganmohan Rao L, Sakariah K. Antioxidant activities of curcumin, demethoxycurcumin and bisdemethoxycurcumin. Food Chem 2006;98:720-4.
5. Kohli K, Ali J, Ansari M, Raheman Z. Curcumin: A natural antiinflammatory agent. Indian J Pharmacol 2005;37:141.
6. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: Problems and promises. Mol Pharmaceut 2007;4:807-18.
7. Ireson CR, Jones DJ, Orr S, Coughtrie MW, Boocock DJ, Williams ML, et al. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epiderm Biomar 2002;11:105-11.
8. Vareed SK, Kakarala M, Ruffin MT, Crowell JA, Normolle DP, Djuric Z, et al. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev 2008;17:1411-7.
9. Mishra S, Narain U, Mishra R, Misra K. Design, development and synthesis of mixed bioconjugates of piperic acid-glycine, curcumin-glycine/alanine and curcumin-glycine-piperic acid and their antibacterial and antifungal properties. Bioorg Med Chem 2005;13:1477-86.
10. Venkatesha SH, Yu H, Rajaiah R, Tong L, Moudgil KD. Celastrusderived celastrol suppresses autoimmune arthritis by modulating antigen-induced cellular and humoral effector responses. J Biol Chem 2011;286:15138-46.
11. Moon DO, Kim MO, Choi YH, Park YM, Kim GY. Curcumin attenuates inflammatory response in IL-1-induced human synovial fibroblasts and collagen-induced arthritis in mouse model. Int Immunopharmacol 2010;10:605-10.
12. Venkatesha SH, Berman BM, Moudgil KD. Herbal medicinal products target defined biochemical and molecular mediators of inflammatory autoimmune arthritis. Bioorg Med Chem 2011;19:21-9.
13. Masaki K, Taketani M, Imai T. First-pass hydrolysis of a propranolol ester derivative in rat small intestine. Drug Metab Dispos 2006;34:398-404.
14. Dixit P, Jain DK, Dumbwani J. Standardization of an ex vivo method for determination of intestinal permeability of drugs using everted rat intestine apparatus. J Pharmacol Toxicol Methods 2012;65:13-7.
15. Wahlang B, Pawar YB, Bansal AK. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur J Pharm Biopharm 2011;77:275-82.
16. Sintara K, Thong-Ngam D, Patumraj S, Klaikeaw N, Chatsuwan T. Curcumin suppresses gastric NF-B activation and macromolecular leakage in Helicobacter pylori-infected rats. World J Gastroenterol 2010;16:4039.
17. Li X, Bradford BU, Dalldorf F, Goyert SM, Stimpson SA, Thurman RG, et al. CD14 mediates the innate immune responses to arthritopathogenic peptidoglycan-polysaccharide complexes of Grampositive bacterial cell walls. Arthritis Res Ther 2004;6:R273-81.
18. Kannan K, Ortmann RA, Kimpel D. Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiol 2005;12:167-81.
19. Koga T, Kakimoto K, Hirofuji T, Kotani S, Ohkuni H, Watanabe K, et al. Acute joint inflammation in mice after systemic injection of the cell wall, its peptidoglycan, and chemically defined peptidoglycan subunits from various bacteria. Infect Immun 1985;50:27-34.
20. Majumdar S, Mueller-Spaeth M, Sloan KB. Prodrugs of Theophylline Incorporating Ethyleneoxy Groups in the Promoiety: Synthesis, Characterization, and Transdermal Delivery. AAPS Pharmscitech 2012;13:853-62.
21. Pfeiffer E, Höhle S, Solyom AM, Metzler M. Studies on the stability of turmeric constituents. J Food Eng 2003;56:257-9.
22. Pearson CM, Wood FD. Studies of polyarthritis and other lesions induced in rats by injection of mycobacterial adjuvant. I. General clinical and pathologic characteristics and some modifying factors. Arthritis Rheum 1959;2:440-59.